135 related articles for article (PubMed ID: 9580699)
1. Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites.
Li JM; Datto MB; Shen X; Hu PP; Yu Y; Wang XF
Nucleic Acids Res; 1998 May; 26(10):2449-56. PubMed ID: 9580699
[TBL] [Abstract][Full Text] [Related]
2. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
[TBL] [Abstract][Full Text] [Related]
3. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA.
Adnane J; Bizouarn FA; Qian Y; Hamilton AD; Sebti SM
Mol Cell Biol; 1998 Dec; 18(12):6962-70. PubMed ID: 9819384
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site.
Li JM; Nichols MA; Chandrasekharan S; Xiong Y; Wang XF
J Biol Chem; 1995 Nov; 270(45):26750-3. PubMed ID: 7592908
[TBL] [Abstract][Full Text] [Related]
5. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation.
Santini MP; Talora C; Seki T; Bolgan L; Dotto GP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9575-80. PubMed ID: 11493684
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
[TBL] [Abstract][Full Text] [Related]
7. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
8. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
Heegaard AM; Xie Z; Young MF; Nielsen KL
J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
[TBL] [Abstract][Full Text] [Related]
10. The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter.
Koutsodontis G; Moustakas A; Kardassis D
Biochemistry; 2002 Oct; 41(42):12771-84. PubMed ID: 12379120
[TBL] [Abstract][Full Text] [Related]
11. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
[TBL] [Abstract][Full Text] [Related]
12. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1.
Al-Sarraj A; Day RM; Thiel G
J Cell Biochem; 2005 Jan; 94(1):153-67. PubMed ID: 15523672
[TBL] [Abstract][Full Text] [Related]
13. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
14. Differential role for Sp1/Sp3 transcription factors in the regulation of the promoter activity of multiple cyclin-dependent kinase inhibitor genes.
Pagliuca A; Gallo P; Lania L
J Cell Biochem; 2000 Jan; 76(3):360-7. PubMed ID: 10649433
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of the murine Muc5ac mucin gene in epithelial cancer cells by TGF-beta/Smad4 signalling pathway is potentiated by Sp1.
Jonckheere N; Van Der Sluis M; Velghe A; Buisine MP; Sutmuller M; Ducourouble MP; Pigny P; Büller HA; Aubert JP; Einerhand AW; Van Seuningen I
Biochem J; 2004 Feb; 377(Pt 3):797-808. PubMed ID: 14570593
[TBL] [Abstract][Full Text] [Related]
16. B-MYB transactivates its own promoter through SP1-binding sites.
Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
[TBL] [Abstract][Full Text] [Related]
17. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio.
Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P
J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells.
Bai L; Merchant JL
J Biol Chem; 2000 Sep; 275(39):30725-33. PubMed ID: 10899165
[TBL] [Abstract][Full Text] [Related]
20. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
